中外健康文摘
中外健康文摘
중외건강문적
WORLD HEALTH DIGEST
2013年
43期
29-30
,共2页
杜华军%吴之坤%曹楚潇%乐来平%汪名飞%江从庆%陶琦%钱群
杜華軍%吳之坤%曹楚瀟%樂來平%汪名飛%江從慶%陶琦%錢群
두화군%오지곤%조초소%악래평%왕명비%강종경%도기%전군
结肠全切除术%结肠多原发癌%肠梗阻
結腸全切除術%結腸多原髮癌%腸梗阻
결장전절제술%결장다원발암%장경조
Subtotal colectomy%synchornous colon cancer%cecoproctostomy
目的:探讨结肠次全切除、逆蠕动盲直吻合术治疗结肠多原发癌和梗阻性左半结肠癌的疗效。方法回顾性分析一期或分期行结肠次全切除、逆蠕动盲直吻合术治疗的12例同时性结肠多原发癌、梗阻性左半结肠癌以及结肠癌伴多发腺瘤患者的临床资料。结果所有患者无吻合口瘘等严重并发症发生,无手术死亡病例。随访2年(1-3年),2例患者发生肝、肺远处转移,其中1例于术后16月死亡,其余患者未发现复发和转移。术后一年日平均大便次数2(1-3)次,Wexner肛门失禁评分4.0±1.2。结论结肠次全切除、逆蠕动盲直吻合术是治疗结肠多原发癌和梗阻性左半结肠癌的一种安全、有效的术式,但长期肿瘤学疗效需进一步证实。
目的:探討結腸次全切除、逆蠕動盲直吻閤術治療結腸多原髮癌和梗阻性左半結腸癌的療效。方法迴顧性分析一期或分期行結腸次全切除、逆蠕動盲直吻閤術治療的12例同時性結腸多原髮癌、梗阻性左半結腸癌以及結腸癌伴多髮腺瘤患者的臨床資料。結果所有患者無吻閤口瘺等嚴重併髮癥髮生,無手術死亡病例。隨訪2年(1-3年),2例患者髮生肝、肺遠處轉移,其中1例于術後16月死亡,其餘患者未髮現複髮和轉移。術後一年日平均大便次數2(1-3)次,Wexner肛門失禁評分4.0±1.2。結論結腸次全切除、逆蠕動盲直吻閤術是治療結腸多原髮癌和梗阻性左半結腸癌的一種安全、有效的術式,但長期腫瘤學療效需進一步證實。
목적:탐토결장차전절제、역연동맹직문합술치료결장다원발암화경조성좌반결장암적료효。방법회고성분석일기혹분기행결장차전절제、역연동맹직문합술치료적12례동시성결장다원발암、경조성좌반결장암이급결장암반다발선류환자적림상자료。결과소유환자무문합구루등엄중병발증발생,무수술사망병례。수방2년(1-3년),2례환자발생간、폐원처전이,기중1례우술후16월사망,기여환자미발현복발화전이。술후일년일평균대편차수2(1-3)차,Wexner항문실금평분4.0±1.2。결론결장차전절제、역연동맹직문합술시치료결장다원발암화경조성좌반결장암적일충안전、유효적술식,단장기종류학료효수진일보증실。
Objective To assess functional outcome of subtotal colectomy with antiperistaltic cecoproctostomy in the treatment for synchornous colon cancer and obstructive left colon cancer. Methods We retrospectively analyzed the data from 12 patients who underwent one-stage or two-staged subtotal colectomy with antiperistaltic cecoproctostomy for synchornous colon cancer and obstructive left colon cancer. Results There was no surgical mortality. No patient had anastomotic leakage. Al patients were fol owed up for 1-3 years (median, 2 years). Two patients experienced liver and lung metastasis, and one of them died on the 16 month after operation. One year after operation, the number of daily bowel movements are 1-3 times (median, 2 times).The Wexner continence scores were 4.0±1.2. Conclusions Subtotal colectomy with antiperistaltic cecoproctostomy is a safe and effective in the treatment of synchornous colon cancer and obstructive left colon cancer. The long-term oncological results need to be further confirmed.